A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
Condition(s):Advanced Solid TumoursLast Updated:September 2, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumoursLast Updated:September 2, 2022Terminated
Condition(s):Advanced Solid TumorsLast Updated:July 20, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:September 14, 2022Not yet recruiting
Condition(s):Advanced Solid TumorLast Updated:April 29, 2019Unknown status
Condition(s):HER-2 Positive Advanced Solid TumorsLast Updated:July 24, 2023Not yet recruiting
Condition(s):Advanced Solid TumorLast Updated:July 27, 2023Recruiting
Condition(s):Advanced Solid TumorsLast Updated:February 24, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:July 7, 2022Recruiting
Condition(s):Advanced Solid TumorLast Updated:June 5, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:March 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.